Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 87

1.

Screening for dyslipidemia.

Froom J, Brook S, Froom P, Benjamin M, Benjamin B.

J Am Board Fam Pract. 1998 May-Jun;11(3):250. No abstract available.

PMID:
9625522
2.

Screening adults for lipid disorders: recommendations and rationale.

US Preventive Services Task Force.

Am J Prev Med. 2001 Apr;20(3 Suppl):73-6. No abstract available.

PMID:
11306235
3.

Dyslipidemia prevalence in a laboratory initiated screening program.

Emerson JF, Jafari M.

Clin Lab Sci. 2002 Spring;15(2):67-70.

PMID:
12776768
4.

Commentary on: 'Screening for lipid disorders in adults: recommendation and rationale'.

Lloyd M.

Am J Nurs. 2002 Jun;102(6):96. No abstract available.

PMID:
12394085
5.

[Screening of atherogenic hyperlipidemias].

Warnet A.

Rev Infirm. 1991 May 21;41(10):40-3. French. No abstract available.

PMID:
1853055
6.

U.S. Preventive Services Task Force: screening for lipid disorders in adults: recommendations and rationale.

Berg AO, Atkins D; U.S. Preventive Services Task Force.

Am J Nurs. 2002 Jun;102(6):91, 93, 95. Review. No abstract available.

PMID:
12394084
7.

Hyperlipidemia screening is worthwhile.

Freis PC.

Pediatrics. 1980 Mar;65(3):674-5. No abstract available.

PMID:
7360568
8.

USPSTF scales back approach to lipid screening for women.

Campos-Outcalt D.

J Fam Pract. 2008 Nov;57(11):740-2. No abstract available.

PMID:
19006623
9.

[Doubtful advices on cholesterol screening in children].

Ravnskov U.

Ugeskr Laeger. 1993 Jun 14;155(24):1886-7. Danish. No abstract available.

PMID:
8317052
10.

Guidelines: more patients should get lipid screenings.

Levenson D.

Rep Med Guidel Outcomes Res. 2001 May 3;12(9):9-10, 12. No abstract available.

PMID:
12113282
11.

An assessment of the new lipid screening guidelines.

Steiner MJ, Brown WD, Liles E.

Pediatrics. 2008 Oct;122(4):904-5; author reply 906-7. doi: 10.1542/peds.2008-2103. No abstract available.

PMID:
18829821
12.

[Methods for primary screening and laboratory diagnosis of dyslipidemia. January 2000 Guidelines. Agence Nationale D'accréditation Et D'évaluation En Santé].

Agence Nationale D'accréditation Et D'évaluation En Santé (ANAES).

J Mal Vasc. 2002 Oct;27(4):226-30. French. No abstract available.

PMID:
12457129
13.

Lipid disorders in athletes.

Reamy BV, Thompson PD.

Curr Sports Med Rep. 2004 Apr;3(2):70-6. Review.

PMID:
14980134
14.

Organising a lipid control regime.

Revill J.

Practitioner. 1994 Dec;238(1545):813-6. No abstract available.

PMID:
7838816
15.

Updated NCEP guidelines set new decision points for managing dyslipidemia.

Stevenson MM.

Geriatrics. 2001 Jul;56(7):50-2, 61. No abstract available.

PMID:
11490987
16.

Relationship between dyslipidemia and the risk of developing end-stage renal disease in a screened cohort.

Iseki K, Tozawa M, Ikemiya Y, Kinjo K, Iseki C, Takishita S.

Clin Exp Nephrol. 2005 Mar;9(1):46-52.

PMID:
15830273
17.

Screening for presence of deficiency, toxicity, and disease.

U. S. Preventive Services Task Force.

Nutr Clin Care. 2003 Oct-Dec;6(3):120-2.

PMID:
14979455
18.

Health-related quality of life with coronary heart disease prevention and treatment.

Lalonde L, Clarke AE, Joseph L, Mackenzie T, Grover SA; Canadian Collaborative Cardiac Assessment Group.

J Clin Epidemiol. 2001 Oct;54(10):1011-8.

PMID:
11576812
19.

Screening and treating adults for lipid disorders.

Pignone MP, Phillips CJ, Atkins D, Teutsch SM, Mulrow CD, Lohr KN.

Am J Prev Med. 2001 Apr;20(3 Suppl):77-89.

PMID:
11306236
20.

Obese African Americans: the prevalence of dyslipidemia, hypertension, and diabetes mellitus.

Randall OS, Retta TM, Kwagyan J, Gordeuk VR, Xu S, Maqbool AR, Ketete M, Obisesan TO.

Ethn Dis. 2004 Summer;14(3):384-8.

PMID:
15328940
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk